Psoriasis and multiple sclerosis – hidden link?

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 31, Iss. 12, 2017-12 ,pp. : 1949-1949

John Wiley & Sons Inc

Access to resources Recommend Favorite

NEUROLOGICAL DISABILITY ASSESSMENT OF MULTIPLE SCLEROSIS IN JAPAN

By  

ACTA NEUROLOGICA SCANDINAVICA (ELECTRONIC), Vol. 64, Iss. S87, 1981-10 ,pp. : 66-68

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of smoking on response to systemic treatment in patients with psoriasis: a retrospective case–control study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 2, 2015-02 ,pp. : 428-436

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis

By Bergvall Niklas   Makin Charles   Lahoz Raquel   Agashivala Neetu   Pradhan Ashish   Capkun Gorana   Petrilla Allison   Karkare Swapna U.   Balderston McGuiness Catherine   Korn Jonathan R.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1647-1656

Informa Healthcare

Access to resources Recommend Favorite

Natalizumab improves ambulation in relapsing−remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM

By  

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22, Iss. 3, 2015-03 ,pp. : 570-577

John Wiley & Sons Inc

Access to resources Recommend Favorite